CTKBCytek Biosciences, Inc.UptrendEarnings in 8 days

TodayUptrendjumpy stock

Nasdaq GSMedical DevicesMarket cap $765.60MReports Nov 4, 2026

Cytek Biosciences, Inc.

Life science tools
Sector
Healthcare
Industry
Medical Devices
Market cap
$765.60M
Employees
682
Exchange
Nasdaq GS
Country
United States
5.89+5.37% todayClose of Oct 26, 2026 · end-of-day snapshot

Not sure what's inside? Read a full TSLA analysis, currently free

Figures as of Oct 26, 2026Unlock all 8$9.90one-time

Technical readingsFree

Trend state Uptrend, stage 2 of 4, 1 of 4 damage flags raised (as of Oct 26, 2026)

Automated read

The moving-average structure shows no decisive trend in either direction: the mid-term picture reads as rangebound. RSI is currently 65.

Readings, end-of-day Oct 26, 2026
RSI (14)Upper-neutral64.74, favorable reading
MACD / signalAbove signal line0.09 / 0.09, favorable reading
SMA 50Price above5.16, favorable reading
SMA 200Price above4.64, favorable reading
EMA 20Price above5.46, favorable reading
ADX (14)Rangebound17.67
Show all 12 readings
+DI / −DI+DI leading24.38 / 14.85
ATR (14)4.5% of price — typical daily swing0.27
Stochastic %KOverbought zone99.41, flagged reading
Bollinger bands (20)Inside bands5.01 – 6.06
ROC (10)Positive over 10 sessions10.92, favorable reading
Trend / momentum impulseTrend and momentum agreeBoth rising, favorable impulse reading
Full analysis

What unlocking CTKB reveals

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock
Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock
AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock
Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock
Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when CTKB's analysis runs, rather than checked against its stored data now.

Every section above, argued on CTKB's own numbers, on one page.

See what CTKB costsNot sure what's inside? Read a full TSLA analysis, currently free

Unlock the full CTKB analysis

AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.

  • Unlocked in about 60 seconds
  • No account needed
  • Secure checkout via Stripe

Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.

Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get CTKB + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
Earnings

When does Cytek Biosciences, Inc. report earnings?

Cytek Biosciences, Inc. (CTKB) is scheduled to report earnings on Nov 4, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Oct 27, 2026

See who else reports soon
Data dictionary
$9.90one-time Unlock CTKB